摘要 |
A compound having a structure according to Formula (I) wherein: R1 is H; R2 is hydrogen, alkyl, or acyl; A is COR3 or SO2R4 wherein R3 is alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino and R4 is alkyl, heteroalkyl, aryl, or heteroaryl, substituted or unsubstituted; X is O, S, SO, SO2, or NR5, wherein R5 is independently chosen from hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, S02R6, COR7, CURS, PO(R9)2 or may optionally form a ring with W or Y; and R6 is alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino; R7 is hydrogen, alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino; R8 is alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino; R9 is alkyl, aryl, heteroaryl, heteroalkyl; W is hydrogen or one or more lower alkyl moieties, or is an alkylene, arylene or heteroarylene bridge between two adjacent or nonadjacent carbons (thus forming a fused ring); Y is independently one or more of hydrogen, hydroxy, SR10, SOR4, SO2R4, alkoxy, amino, wherein amino is of formula NR11,R12, wherein R11 and R12 are independently chosen from hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, SO2R6, COR7, CUR8, PO(R9)2; and R10 is hydrogen, alkyl, aryl, heteroaryl; Z is nil, a spiro moiety or an oxo group substituted on the heterocyclic ring and n is 1-4. These compounds are useful as metalloprotease inhibitors.
|